Cargando…

Synergistic Effect of Doripenem and Cefotaxime to Inhibit CTX-M-15 Type β-Lactamases: Biophysical and Microbiological Views

CTX-M-15 type β-lactamase has the ability to hydrolyse cefotaxime, a third generation cephalosporin. The infections caused by multidrug resistant strains, especially CTX-M-15 producing strains are being treated with carbapenem group of β-lactam antibiotics. The objective of the study was to know if...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maryam, Lubna, Khan, Asad U.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5496960/ https://www.ncbi.nlm.nih.gov/pubmed/28725196 http://dx.doi.org/10.3389/fphar.2017.00449

Ejemplares similares

A Mechanism of Synergistic Effect of Streptomycin and Cefotaxime on CTX-M-15 Type β-lactamase Producing Strain of E. cloacae: A First Report
por: Maryam, Lubna, et al.
Publicado: (2016)

Interaction of CTXM15 enzyme with cefotaxime: a molecular modelling and docking study
por: Shakil, Shazi, et al.
Publicado: (2010)

Significant role of Asn-247 and Arg-64 residues in close proximity of the active site in maintaining the catalytic function of CTX-M-15 type β-lactamase
por: Maryam, Lubna, et al.
Publicado: (2019)

Synergistic effects of baicalein with cefotaxime against Klebsiella pneumoniae through inhibiting CTX-M-1 gene expression
por: Cai, Wenhui, et al.
Publicado: (2016)

Biochemical Characterization of CTX-M-15 from Enterobacter cloacae and Designing a Novel Non-β-Lactam-β-Lactamase Inhibitor
por: Faheem, Mohammad, et al.
Publicado: (2013)

Correction: Biochemical Characterization of CTX-M-15 from Enterobacter cloacae and Designing a Novel Non-β-Lactam-β-Lactamase Inhibitor
por: Faheem, Mohammad, et al.
Publicado: (2013)

Translational Inhibition of CTX-M Extended Spectrum β-Lactamase in Clinical Strains of Escherichia coli by Synthetic Antisense Oligonucleotides Partially Restores Sensitivity to Cefotaxime
por: Readman, John B., et al.
Publicado: (2016)

Collateral sensitivity constrains resistance evolution of the CTX-M-15 β-lactamase
por: Rosenkilde, Carola E. H., et al.
Publicado: (2019)

In vivo / in vitro Correlation of Pharmacokinetics of Gentamicin, Vancomycin, Teicoplanin and Doripenem in a Bovine Blood Hemodialysis Model
por: Vossen, M G, et al.
Publicado: (2021)

Structure, Genetics and Worldwide Spread of New Delhi Metallo-β-lactamase (NDM): a threat to public health
por: Khan, Asad U., et al.
Publicado: (2017)

Enzyme Efficiency but Not Thermostability Drives Cefotaxime Resistance Evolution in TEM-1 β-Lactamase
por: Knies, Jennifer L., et al.
Publicado: (2017)

CTX-M-14 and CTX-M-15 enzymes are the dominant type of extended-spectrum β-lactamase in clinical isolates of Escherichia coli from Korea
por: Song, Wonkeun, et al.
Publicado: (2009)

Molecular detection of CTX-M-15-type β-lactamases in Escherichia coli strains from Senegal
por: Dia, M.L., et al.
Publicado: (2015)

Optimal dose of cefotaxime in neonates with early-onset sepsis: A developmental pharmacokinetic model-based evaluation
por: Shang, Zhen-Hai, et al.
Publicado: (2022)

Extended spectrum β-lactamase-producing Escherichia coli forms filaments as an initial response to cefotaxime treatment
por: Kjeldsen, Thea SB, et al.
Publicado: (2015)

CTX-M Extended-spectrum β-Lactamases, Washington State
por: Kim, Seonghan, et al.
Publicado: (2007)

Dissemination of Clonally Related Escherichia coli Strains Expressing Extended-Spectrum β-Lactamase CTX-M-15
por: Coque, Teresa M., et al.
Publicado: (2008)

Both the mono- and di-anions of ellagic acid are effective inhibitors of the serine β-lactamase CTX-M-15
por: Talbot, Nathan, et al.
Publicado: (2019)

A mechanistic approach to prove the efficacy of combination therapy against New Delhi metallo-β-lactamases producing bacterial strain: a molecular and biochemical approach
por: Maryam, Lubna, et al.
Publicado: (2020)

Salmonella enterica Serovar Typhi with CTX-M β-Lactamase, Germany
por: Pfeifer, Yvonne, et al.
Publicado: (2009)

Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study
por: Noguchi, Taro, et al.
Publicado: (2017)

In vitro and in vivo efficacy study of cefepime, doripenem, tigecycline, and tetracycline against extended-spectrum beta-lactamases Escherichia coli in chickens
por: Tarazi, Yaser Hamadeh, et al.
Publicado: (2020)

Uncovering the Important Genetic Factors for Growth during Cefotaxime-Gentamicin Combination Treatment in bla(CTX-M-1) Encoding Escherichia coli
por: Alobaidallah, Mosaed Saleh A., et al.
Publicado: (2023)

Antibiogram and beta-lactamase genes among cefotaxime resistant E. coli from wastewater treatment plant
por: Adegoke, Anthony Ayodeji, et al.
Publicado: (2020)

Transcriptome analysis of extended-spectrum β-lactamase-producing Escherichia coli and methicillin-resistant Staphylococcus aureus exposed to cefotaxime
por: Brochmann, P. R., et al.
Publicado: (2018)

Role of CTX-M-15 gene in spread of extended-spectrum beta-lactamases among immunocompetent patients in Ghana
por: Obeng-Nkrumah, Noah, et al.
Publicado: (2023)

Prolonged febrile illness due to CTX-M-15 extended-spectrum β-lactamase-producing Klebsiella pneumoniae infection in Nigeria
por: Aboderin, Oladipo A., et al.
Publicado: (2012)

Complete Genome Sequences of Two Phage-Like Plasmids Carrying the CTX-M-15 Extended-Spectrum β-Lactamase Gene
por: Colavecchio, Anna, et al.
Publicado: (2017)

Evaluation of quercetin as a potential β-lactamase CTX-M-15 inhibitor via the molecular docking, dynamics simulations, and MMGBSA
por: SARIYER*, Emrah, et al.
Publicado: (2021)

CTX-M-14 β-lactamase-producing Citrobacter freundii isolated in Venezuela
por: Millán, Beatriz, et al.
Publicado: (2011)

Human Salmonella Infection Yielding CTX-M β-Lactamase, United States
por: Sjölund, Maria, et al.
Publicado: (2008)

Escherichia coli Producing CTX-M-2 β-Lactamase in Cattle, Japan
por: Shiraki, Yutaka, et al.
Publicado: (2004)

CTX-M β-Lactamase Production and Virulence of Escherichia coli K1
por: Dubois, Damien, et al.
Publicado: (2009)

Molecular Basis for the Catalytic Specificity of the CTX-M Extended-Spectrum β-Lactamases
por: Adamski, Carolyn J., et al.
Publicado: (2014)

Characteristics of doripenem: a new broad-spectrum antibiotic
por: Alvarez-Lerma, Francisco, et al.
Publicado: (2009)

Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii
por: Maifiah, Mohd Hafidz Mahamad, et al.
Publicado: (2017)

AFM Probing the Mechanism of Synergistic Effects of the Green Tea Polyphenol (−)-Epigallocatechin-3-Gallate (EGCG) with Cefotaxime against Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli
por: Cui, Yidan, et al.
Publicado: (2012)

Penicillanic Acid Sulfones Inactivate the Extended-Spectrum β-Lactamase CTX-M-15 through Formation of a Serine-Lysine Cross-Link: an Alternative Mechanism of β-Lactamase Inhibition
por: Hinchliffe, Philip, et al.
Publicado: (2022)

CEFOTAXIME IN THE TREATMENT OF BACTERIAL MENINGITIS
por: Asmar, Basim I, et al.
Publicado: (1984)

Tolerability, Safety, Pharmacokinetics and Drug Interaction of Cefotaxime Sodium–Tazobactam Sodium Injection (6:1) Following Single and Multiple Intravenous Doses in Chinese Healthy Subjects
por: Chen, Ning, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vm1rqv5fh26o2ls0lujsng0sjg